Health
Pfizer profit falls 32per cent as global trial of COVID-19 vaccine candidate begins – CNA
Pfizer Inc reported a 32per cent fall in second-quarter profit on Tuesday due to a dip in demand for some of its drugs from the COVID-19 pandemic and from rising competition, as the company and partner began a global study into a vaccine candidate to fight t…
REUTERS: Pfizer Inc on Tuesday said other developed countries would not get a lower price for its coronavirus vaccine than what it will charge the United States under a contract announced last week.
The U.S. government agreed to pay nearly US$2 billion to buy enough of a COVID-19 vaccine being developed by Pfizer and German biotech BioNTech SE to inoculate 50 million people at a price of US$39 for a two-dose treatment course.
Advertisement
Advertisement
That deal likely set a global benchmar…
-
General13 hours agoICAC investigating University of Wollongong as chancellor grilled at Inquiry
-
General22 hours agoTwo people arrested after man fatally shot at McLaren Flat
-
General20 hours agoWarner Bros Discovery board rejects rival $163bn bid from Paramount
-
Noosa News12 hours agoE-Scooter accident | Noosa Today